Neurotransmitter regulation of somatostatin secretion by fetal rat cerebral cortical cells in culture. 1993

M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
Servicio de Endocrinología, Hospital Ramón y Cajal, Madrid, Spain.

Extensive studies exploring the regulation of hypothalamic somatostatin GHRIH release have been reported, but the factors regulating GHRIH release in the cerebral cortex have not been well defined. We have studied the effects of central neurotransmitters on GHRIH secretion by cultured fetal rat cerebral cortical cells and on intracellular GHRIH levels. Cells maintained in vitro for 15-20 days were incubated with dopamine (DA), acetylcholine (ACh), gamma-aminobutyric acid (GABA), norepinephrine (NE), serotonin (SE) or histamine (His) (10(-11) M to 10(3) M) for 30 minutes. Following incubation, immunoreactive GHRIH was measured by RIA in cell extracts and incubation media. DA increased intracellular GHRIH content but have no effect on GHRIH in the media. Both media and intracellular GHRIH content were significantly reduced by GABA and SE. The effect of NE was stimulatory at low (10(-9) M) and inhibitory at high (10(-5) M to 10(-3) M) concentrations. ACh was found to increase media GHRIH and to decrease intracellular GHRIH content; 30 min exposure to His did not significantly modify either media or intracellular GHRH. Our findings with fetal rat cerebral cortical cells in culture demonstrate that endogenous neurotransmitters do have the capacity to directly influence GHRIH regulation.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
December 1991, Endocrinology,
M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
August 1983, Endocrinology,
M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
June 1990, The American journal of physiology,
M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
January 1985, Endocrinology,
M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
October 2001, Brain research. Molecular brain research,
M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
May 1983, Journal of neurochemistry,
M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
February 1982, Endocrinology,
M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
February 1980, Nature,
M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
April 1993, Journal of molecular endocrinology,
M T de los Frailes, and L Cacicedo, and M J Lorenzo, and R M Tolón, and G Fernández, and F Sánchez Franco
January 1981, Endocrinology,
Copied contents to your clipboard!